Tendencias en la mortalidad por cáncer en México de 1980 a 2011

Torres‐Sánchez, Luisa; Rojas‐Martínez, Rosalba; Escamilla-Núñez, Consuelo; Vara-Salazar, Elvia de la; Lazcano‐Ponce, Eduardo

doi:10.21149/spm.v56i5.7373

Cited by 31 publications

(29 citation statements)

References 36 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Previous publications describing the burden of cancer in Mexico have been limited in scope because of the analysis of only short time periods, inclusion of a limited number of cancers, [20][21][22][23][24][25][26][27] incomplete or too broad geographical coverage, [28][29][30][31] or special settings like the population covered by the social security system. [32][33][34] It has therefore been difficult to assess cancer trends across the country.…”

Section: Discussionmentioning

confidence: 99%

“…The problem with garbage codes in the Mexican vital statistics has been addressed by other researchers although their approach has been to treat the unspecified and garbage codes as separated entities. 28 Another difference is that if a cause of death is coded as being due to a benign neoplasms it is being redistributed to the complementary malignant neoplasm in the GBD 2013 study. The overall increase in the GBD mortality estimates after redistribution of different categories of garbage codes was the highest for uterine (37% increase) and cervical (33% increase) cancers.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

The burden of cancer in Mexico, 1990-2013

et al. 2016

View full text Add to dashboard Cite

Objective. To analyze mortality and incidence for 28 cancers by deprivation status, age and sex from 1990 to 2013. Materials and methods. The data and methodological approaches provided by the Global Burden of Disease (GBD 2013) were used. Results. Trends from 1990 to 2013 show important changes in cancer epidemiology in Mexico. While some cancers show a decreasing trend in incidence and mortality (lung, cervical) others emerge as relevant health priorities (prostate, breast, stomach, colorectal and liver cancer). Age standardized incidence and mortality rates for all cancers are higher in the northern states while the central states show a decreasing trend in the mortality rate. The analysis show that infection related cancers like cervical or liver cancer play a bigger role in more deprived states and that cancers with risk factors related to lifestyle like colorectal cancer are more common in less marginalized states. Conclusions. The burden of cancer in Mexico shows complex regional patterns by age, sex, types of cancer and deprivation status. Creation of a national cancer registry is crucial.Keywords: cancer; burden of disease; mortality; incidence; social condition; cause of death; epidemiology ResumenObjetivo. Analizar la incidencia y la mortalidad de 28 tipos de cáncer por nivel de marginación, grupos de edad y sexo, de 1990 a 2013. Material y métodos. Los datos utilizados provienen del estudio de la Carga Global de Enfermedades (2013). Las entidades federativas se clasificaron de acuerdo con el índice de marginación del Consejo Nacional de Población. Resultados. Los datos muestran una tendencia decreciente para algunos cánceres (pulmón y cervical), mientras otros aparecen como prioritarios y relevantes (próstata, mama, estómago, colon e hígado). En el norte se observan incrementos regionales mayores en las tasas de incidencia y mortalidad estandarizadas por edad, mientras que en los estados del centro se observa una tendencia decreciente de la tasa de mortalidad. Conclusiones. La epidemiología del cáncer en México (en su mayoría basada en datos de mortalidad) presentan patrones regionales complejos por edad, sexo, tipo de cáncer e índice de marginación. Es vital la creación de un registro nacional para mejorar el seguimiento y evaluación de intervenciones preventivas y curativas.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

The burden of cancer in Mexico, 1990-2013

et al. 2016

View full text Add to dashboard Cite

show abstract

“…Leticia Torres-Ibarra, MSc, (1,2) Eduardo Lazcano-Ponce, DSc, (1) Eduardo L Franco, DPH, (3) Jack Cuzick, PhD,…”

Section: Triage Strategies In Cervical Cancer Detection In Mexico: Mementioning

confidence: 99%

“…Consequently, secondary prevention must be strengthened, particularly in developing nations where cervical cancer is among the leading causes of cancer-related mortality for women. 1,2 New technological advances have the potential to increase the effectiveness of programs for the secondary prevention of cancer. These new tools include the detection of high-risk HPV types (hrHPV).…”

Section: Triage Strategies In Cervical Cancer Detection In Mexico: Mementioning

confidence: 99%

Triage strategies in cervical cancer detection in Mexico: methods of the FRIDA Study

et al. 2016

Self Cite

View full text Add to dashboard Cite

Objective. This paper describes the study design and baseline characteristics of the study population, including the first 30 829 women who enrolled in the Forwarding Research for Improved Detection and Access for Cervical Cancer Screening and Triage (FRIDA Study). This is a large population based study that is evaluating the performance and cost-effectiveness of different triage strategies for high-risk HPV (hrHPV) positive women in Mexico. Materials and methods. The target population is more than 100 000 women aged 30 to 64 years who attend the Cervical Cancer Screening Program in 100 health centers in the state of Tlaxcala, Mexico. Since August 2013, all women in the region have been invited to ResumenObjetivo.

show abstract

“…Diagnosis requires resources, time, technology, and personnel, among other factors. [71][72][73] Thus, completion of follow-up with women with abnormal mammography findings is an important goal. In accordance with Bairati and colleagues, continuity of care is the mediator through which services are received as coordinated and uninterrupted events consistent with the medical needs of the patients.…”

Section: Signs and Symptomsmentioning

confidence: 99%

Effect of care-delivery delay on the survival of Mexican women with breast cancer

et al. 2016

Self Cite

View full text Add to dashboard Cite

Efecto de la demora en la atención sobre la supervivencia de mujeres mexicanas con cáncer de mama. Salud Publica Mex 2016;58:237-250. ResumenObjetivo. Estimar el efecto del tiempo de atención sobre la supervivencia de mujeres con cáncer de mama. Material y métodos. Se realizó el análisis retrospectivo de 854 mujeres atendidas en 11 hospitales entre 2007 y 2009. Se emplearon estimadores de Kaplan-Meier y un modelo de riesgos proporcionales de Cox. Resultados. 10.5% se diagnosticó en etapa I, mientras que 82.1% demoró más de 67 días entre la percepción de un síntoma y el inicio del tratamiento. La mediana del tiempo desde la entrega de los resultados de la mastografía hasta la biopsia fue de 31 días (RIQ 14-56); en comparación con quienes se encontraron en el cuartil 1 (Q1), la supervivencia fue menor en aquellas que se encontraron en los Q3 y Q4 (HR=1.68, IC95% 0.94-3.00; HR=1.76, IC95% 1.04-2.98, respectivamente). Conclusiones. Se sugiere reducir el tiempo desde la entrega de los resultados de la mastografía a la biopsia diagnóstica para incrementar la supervivencia.Palabras clave: cáncer de mama; demora en la atención; supervivencia; México The median time from receipt of results of the mammography to biopsy was 31 days (IQR 14-56). Compared with those who were in quartile I (Q1), survival was lower among those in Q3 and Q4 (HR=1.68, 95%CI 0.94-3.00; HR=1.76, 95% CI 1.04-2.98, respectively). Conclusions. To increase survival, it is suggested that the time between receipt of the mammography results and diagnostic biopsy be reduced.

show abstract

Tendencias en la mortalidad por cáncer en México de 1980 a 2011

Cited by 31 publications

References 36 publications

The burden of cancer in Mexico, 1990-2013

The burden of cancer in Mexico, 1990-2013

Triage strategies in cervical cancer detection in Mexico: methods of the FRIDA Study

Effect of care-delivery delay on the survival of Mexican women with breast cancer

Contact Info

Product

Resources

About